Table 1 Clinicopathologic parameters of 33 samples from HMU
No. | Age range | Pathology (WHO) | No. | Age range | Pathology (WHO) |
|---|---|---|---|---|---|
01 | 60–69 | Brain Tissue | 17 | 20–29 | Pleomorphic Xanthoastrocytoma II |
02 | 50–59 | Brain Tissue | 18 | 30–39 | Diffuse Astrocytoma II |
03 | 70–79 | Brain Tissue | 19 | 40–49 | Anaplastic Oligoastrocytoma III |
04 | 50–59 | Brain Tissue | 20 | 20–29 | Anaplastic Astrocytoma III |
05 | 60–69 | Astrocytoma I | 21 | 40–49 | Anaplastic Oligoastrocytoma III |
06 | 30–39 | Astrocytoma I | 22 | 50–59 | Anaplastic Astrocytoma III |
07 | 30–39 | Astrocytoma I | 23 | 50–59 | Anaplastic Astrocytoma III |
08 | 60–69 | Astrocytoma I | 24 | 20–29 | Glioblastoma IV |
09 | 40–49 | Astrocytoma I | 25 | 50–59 | Glioblastoma IV |
10 | 70–79 | Oligoastrocytoma II | 26 | 40–49 | Glioblastoma IV |
11 | 30–39 | Oligoastrocytoma II | 27 | 50–59 | Glioblastoma IV |
12 | 40–49 | Astrocytoma II | 28 | 40–49 | Glioblastoma IV |
13 | 40–49 | Diffuse Astrocytoma II | 29 | 30–39 | Glioblastoma IV |
14 | 30–39 | Diffuse Astrocytoma II | 30 | 50–59 | Glioblastoma IV |
15 | 60–69 | Diffuse Astrocytoma II | 31 | 70–79 | Glioblastoma IV |
16 | 40–49 | Oligodendroglioma II | 32 | 60–69 | Glioblastoma IV |
33 | 40–49 | Glioblastoma IV |  | ||